Marrone Bio Innovations collaborating with Terramera


Marrone Bio Innovations, Inc. (MBI) and Terramera are collaborating to combine their technological and biological expertise to enhance the performance of MBI’s crop protection products and expedite product development.

The collaboration is expected to provide a unique platform that will bring existing and new biologicals to market. It will be supported by Terramera’s artificial intelligence-based screening platform of novel adjuvants, Plant Intelligence Engine, and its Actigate technology, a proprietary green chemistry that delivers active ingredients directly into target cells.

Marrone Bio will look to use the technology to increase the performance and consistency of its new and existing active ingredients including Regalia biofungicide, the newly developed Stargus biofungicide, Venerate XC bioinsecticide, and Grandevo WDG bioinsecticide.
“We are always looking for ways we can innovate and partner with companies that share our commitment to creating new technologies which support sustainable agriculture and enhance our ability to develop original products that provide growers with increased efficacy and industry-leading ROI,” stated Kevin Helash, chief executive officer of Marrone Bio Innovations. “We believe that collaborating with a leader in greentech, such as Terramera, will allow both organizations to capitalize on some of the most robust technical algorithms in the industry and provide an opportunity to enhance the specificity and value of our products. Perhaps most exciting is how this partnership has the potential to expedite our product pipeline and allow us to bring more novel products to market faster, such as a bioherbicide currently in development.”
Karn Manhas, Terramera founder and CEO, said the company is “excited to work with Marrone Bio. “Collaborating with Marrone Bio Innovations, a recognized global leader in developing sustainable biopesticide solutions, advances Terramera’s goal of reducing the synthetic pesticide load in agriculture by 80 percent.”
In addition to this collaboration, field trials are planned to test performance of the combination of two commercially available products, MBI’s Venerate XC Bioinsecticide and Terramera’s Rango. Additional trials are contemplated for spring 2022.
 Read our latest issue  HERE !

New AG International November/December 2020

Check out our new digital publication in Spanish HERE!

cover 199x282


News From Suppliers